US Stock MarketDetailed Quotes

SKYE SKYE BIOSCIENCE INC

Watchlist
  • 12.325
  • +0.075+0.61%
Trading May 17 10:09 ET
345.94MMarket Cap-2948P/E (TTM)

About SKYE BIOSCIENCE INC Company

Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include nimacimab and SBI-100 Ophthalmic Emulsion. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.

Company Profile

SymbolSKYE
Company NameSKYE BIOSCIENCE INC
Issue Price0.05
Founded2011
CEODr. Brian S. Murphy
MarketNASDAQ
Employees11
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address11250 El Camino Real,Suite 100
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-858-410-0266
Websitehttp://skyebioscience.com

Company Executives

  • Name
  • Position
  • Salary
  • Punit Dhillon
  • Chairman of the Board and Chief Executive Officer
  • --
  • Dr. Brian S. Murphy
  • Chief Executive Officer, Chief Medical Officer and Director
  • --
  • Kaitlyn Arsenault
  • Chief Financial Officer
  • --
  • Elizabeth M. Berecz
  • Principal Accounting Officer, Chief Financial Officer and Secretary
  • --
  • Punit Dhillon
  • Director
  • --
  • James (Jim) Heppell
  • Director
  • --
  • Praveen Tyle
  • Independent Director
  • --
  • Margaret Dalesandro
  • Independent Director
  • --
  • Keith Ward
  • Independent Director
  • --
  • Deborah Charych
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg